ABOUT BETTER THERAPEUTICS
Better Therapeutics discovers, develops and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. We use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases thereby improving quality of life, reducing the need for medications, and lowering costs. Our products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app, and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Our current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia.
Our founding team has started, led and exited multiple technology companies that have transformed industries and generated billions of dollars in enterprise value. The 17th Surgeon General of the US, Dr. Richard Carmona, serves as an independent board director.
We were founded in 2015 and are headquartered in San Francisco, CA.
To make the benefits of behavioral therapy accessible and affordable to everyone.
To become the most commonly prescribed treatment for cardiometabolic diseases in the world.
We believe software is on the verge of disrupting medicine and may become the standard of care for treating diseases caused by behaviors. We have validated the clinical effectiveness of our software in peer-reviewed and published clinical trials, and are beginning to commercialize with private health insurers while pursuing FDA clearance to our first indication in diabetes.